Synta to Present at Upcoming Conferences

  Synta to Present at Upcoming Conferences

Business Wire

LEXINGTON, Mass. -- February 11, 2013

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company
will present at the following investor conferences:

Leerink Swann Global Healthcare Conference in New York
Wednesday, February 13, at 8:30 a.m. (EST)

Cowen and Company 33^rd Annual Healthcare Conference in Boston
Monday, March 4, at 3:30 p.m. (EST)

Barclays Global Healthcare Conference in Miami
Tuesday, March 12, at 3:45 p.m. (EST)

25^th Annual ROTH Conference in Laguna Niguel, CA
Tuesday, March 19, at 10:00 a.m. (PST) / 1:00 p.m. (EST)

Live audio webcasts and replays of these presentations will be available on
the "Investors" section of the Company's website, www.syntapharma.com.

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to extend
and enhance the lives of patients with severe medical conditions, including
cancer and chronic inflammatory diseases. Synta has a unique chemical compound
library, an integrated discovery engine, and a diverse pipeline of clinical-
and preclinical-stage drug candidates with distinct mechanisms of action and
novel chemical structures. All Synta drug candidates were invented by Synta
scientists using our compound library and discovery capabilities. For more
information, please visit www.syntapharma.com.

Contact:

Synta Pharmaceuticals Corp.
George Farmer, 781-541-7213
 
Press spacebar to pause and continue. Press esc to stop.